The DOI matches its Crossref record; 159 of the 159 references it cites were found in a registry or an index.
The diverse and complex roles of NF-κB subunits in cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
Veuger, S. J., Hunter, J. E., & Durkacz, B. W. (2008) · Oncogene · doi:10.1038/onc.2008.439 · Cited by 135
RetractedRetracted: A cell cycle regulatory network controlling NF‐κB subunit activity and function
Barré, B., & Perkins, N. D. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601899 · Cited by 106
Self-citationRetractedBarré, B., & Perkins, N. D. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.03.018 · Cited by 72
Self-citationRetractedRegulation of activity and function of the p52 NF-κB subunit following DNA damage
Barré, B., Coqueret, O., & Perkins, N. D. (2010) · Cell Cycle · doi:10.4161/cc.9.24.14245 · Cited by 28
Self-citationRetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Chen, X., Xiu, M., Xing, J., Yu, S., Min, D., & Guo, F. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479439 · Cited by 5,742
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,494
Activators and target genes of Rel/NF-κB transcription factors
Pahl, H. L. (1999) · Oncogene · doi:10.1038/sj.onc.1203239 · Cited by 3,727
Nuclear factor-κB in cancer development and progression
Karin, M. (2006) · Nature · doi:10.1038/nature04870 · Cited by 3,519
Activators and Target Genes of Rel/NF-кB Transcription Factors: From Bench to Bedside
Loop, T., & Pahl, H. L. (2003) · Nuclear Factor кB · doi:10.1007/978-94-010-0163-2_1 · Cited by 3,169
Patterns of somatic mutation in human cancer genomes
Greenman, C., Stephens, P., Smith, R., Dalgliesh, G. L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C., et al. (2007) · Nature · doi:10.1038/nature05610 · Cited by 3,080
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
IKKβ Links Inflammation and Tumorigenesis in a Mouse Model of Colitis-Associated Cancer
Greten, F. R., Eckmann, L., Greten, T. F., Park, J. M., Li, Z.-W., Egan, L. J., Kagnoff, M. F., & Karin, M. (2004) · Cell · doi:10.1016/j.cell.2004.07.013 · Cited by 2,433
NF-κB functions as a tumour promoter in inflammation-associated cancer
Pikarsky, E., Porat, R. M., Stein, I., Abramovitch, R., Amit, S., Kasem, S., Gutkovich-Pyest, E., Urieli-Shoval, S., Galun, E., & Ben-Neriah, Y. (2004) · Nature · doi:10.1038/nature02924 · Cited by 2,430
Integrating cell-signalling pathways with NF-κB and IKK function
Perkins, N. D. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2083 · Cited by 2,350
Self-citationCOSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer
Forbes, S. A., Bindal, N., Bamford, S., Cole, C., Kok, C. Y., Beare, D., Jia, M., Shepherd, R., Leung, K., Menzies, A., et al. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq929 · Cited by 2,278
RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia
Zuber, J., Shi, J., Wang, E., Rappaport, A. R., Herrmann, H., Sison, E. A., Magoon, D., Qi, J., Blatt, K., Wunderlich, M., et al. (2011) · Nature · doi:10.1038/nature10334 · Cited by 1,870
Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB
Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S., & Baltimore, D. (1995) · Nature · doi:10.1038/376167a0 · Cited by 1,825
Iliopoulos, D., Hirsch, H. A., & Struhl, K. (2009) · Cell · doi:10.1016/j.cell.2009.10.014 · Cited by 1,374
Inflammation meets cancer, with NF-κB as the matchmaker
Ben-Neriah, Y., & Karin, M. (2011) · Nature Immunology · doi:10.1038/ni.2060 · Cited by 1,373
The IKK NF-κB system: a treasure trove for drug development
Karin, M., Yamamoto, Y., & Wang, Q. M. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1279 · Cited by 1,364
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Kawahara, T. L. A., Michishita, E., Adler, A. S., Damian, M., Berber, E., Lin, M., McCord, R. A., Ongaigui, K. C. L., Boxer, L. D., Chang, H. Y., et al. (2009) · Cell · doi:10.1016/j.cell.2008.10.052 · Cited by 1,090
Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Baud, V., & Karin, M. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2781 · Cited by 1,061
Chien, Y., Scuoppo, C., Wang, X., Fang, X., Balgley, B., Bolden, J. E., Premsrirut, P., Luo, W., Chicas, A., Lee, C. S., et al. (2011) · Genes & Development · doi:10.1101/gad.17276711 · Cited by 1,046
Osteopetrosis in mice lacking NF-κB1 and NF-κB2
Iotsova, V., Caamaño, J., Loy, J., Yang, Y., Lewin, A., & Bravo, R. (1997) · Nature Medicine · doi:10.1038/nm1197-1285 · Cited by 990
Nuclear factor-?B: its role in health and disease
Kumar, A., Takada, Y., Boriek, A., & Aggarwal, B. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0555-y · Cited by 933
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
NF- B as a Critical Link Between Inflammation and Cancer
Karin, M. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000141 · Cited by 816
Perkins, N. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209937 · Cited by 674
Self-citationOrjalo, A. V., Bhaumik, D., Gengler, B. K., Scott, G. K., & Campisi, J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905299106 · Cited by 654
Tan, W., Zhang, W., Strasner, A., Grivennikov, S., Cheng, J. Q., Hoffman, R. M., & Karin, M. (2011) · Nature · doi:10.1038/nature09707 · Cited by 647
B-cell-derived lymphotoxin promotes castration-resistant prostate cancer
Ammirante, M., Luo, J.-L., Grivennikov, S., Nedospasov, S., & Karin, M. (2010) · Nature · doi:10.1038/nature08782 · Cited by 639
p53 regulates glucose metabolism through an IKK-NF-κB pathway and inhibits cell transformation
Kawauchi, K., Araki, K., Tobiume, K., & Tanaka, N. (2008) · Nature Cell Biology · doi:10.1038/ncb1724 · Cited by 637
Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK
Dan, H. C., Cooper, M. J., Cogswell, P. C., Duncan, J. A., Ting, J. P.-Y., & Baldwin, A. S. (2008) · Genes & Development · doi:10.1101/gad.1662308 · Cited by 636
IKKα limits macrophage NF-κB activation and contributes to the resolution of inflammation
Lawrence, T., Bebien, M., Liu, G. Y., Nizet, V., & Karin, M. (2005) · Nature · doi:10.1038/nature03491 · Cited by 626
Shangary, S., & Wang, S. (2009) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094723 · Cited by 623
Greten, F. R., Arkan, M. C., Bollrath, J., Hsu, L.-C., Goode, J., Miething, C., Göktuna, S. I., Neuenhahn, M., Fierer, J., Paxian, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.07.009 · Cited by 616
Transcriptional Cross Talk between NF-κB and p53
Webster, G. A., & Perkins, N. D. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3485 · Cited by 598
Self-citationDeletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Inhibitors of NF-κB signaling: 785 and counting
Gilmore, T. D., & Herscovitch, M. (2006) · Oncogene · doi:10.1038/sj.onc.1209982 · Cited by 569
Pulsatile Stimulation Determines Timing and Specificity of NF-κB-Dependent Transcription
Ashall, L., Horton, C. A., Nelson, D. E., Paszek, P., Harper, C. V., Sillitoe, K., Ryan, S., Spiller, D. G., Unitt, J. F., Broomhead, D. S., et al. (2009) · Science · doi:10.1126/science.1164860 · Cited by 543
Madrid, L. V., Wang, C.-Y., Guttridge, D. C., Schottelius, A. J. G., Baldwin, A. S., & Mayo, M. W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1626-1638.2000 · Cited by 540
Mutations in the NF-κB signaling pathway: implications for human disease
Courtois, G., & Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209939 · Cited by 525
Regulation of tissue homeostasis by NF-κB signalling: implications for inflammatory diseases
Pasparakis, M. (2009) · Nature Reviews Immunology · doi:10.1038/nri2655 · Cited by 523
Requirement for NF-κB signalling in a mouse model of lung adenocarcinoma
Meylan, E., Dooley, A. L., Feldser, D. M., Shen, L., Turk, E., Ouyang, C., & Jacks, T. (2009) · Nature · doi:10.1038/nature08462 · Cited by 517
Good cop, bad cop: the different faces of NF-κB
Perkins, N. D., & Gilmore, T. D. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401838 · Cited by 489
Self-citationStaudt, L. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000109 · Cited by 485
Inflammation and oncogenesis: a vicious connection
Grivennikov, S. I., & Karin, M. (2010) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2009.11.004 · Cited by 456
Jmjd3 contributes to the control of gene expression in LPS-activated macrophages
De Santa, F., Narang, V., Yap, Z. H., Tusi, B. K., Burgold, T., Austenaa, L., Bucci, G., Caganova, M., Notarbartolo, S., Casola, S., et al. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.271 · Cited by 421
Context-Specific Regulation of NF-κB Target Gene Expression by EZH2 in Breast Cancers
Lee, S. T., Li, Z., Wu, Z., Aau, M., Guan, P., Karuturi, R. K. M., Liou, Y. C., & Yu, Q. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.011 · Cited by 399
NF-κB controls energy homeostasis and metabolic adaptation by upregulating mitochondrial respiration
Mauro, C., Leow, S. C., Anso, E., Rocha, S., Thotakura, A. K., Tornatore, L., Moretti, M., De Smaele, E., Beg, A. A., Tergaonkar, V., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2324 · Cited by 394
NF-κB and IKK as therapeutic targets in cancer
Kim, H. J., Hawke, N., & Baldwin, A. S. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401877 · Cited by 391
Active Repression of Antiapoptotic Gene Expression by RelA(p65) NF-κB
Campbell, K. J., Rocha, S., & Perkins, N. D. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00131-5 · Cited by 386
Self-citationBollrath, J., & Greten, F. R. (2009) · EMBO reports · doi:10.1038/embor.2009.243 · Cited by 383
The nuclear signaling of NF-κB: current knowledge, new insights, and future perspectives
Wan, F., & Lenardo, M. J. (2010) · Cell Research · doi:10.1038/cr.2009.137 · Cited by 370
Posttranslational modifications of NF-κB: Another layer of regulation for NF-κB signaling pathway
Huang, B., Yang, X.-D., Lamb, A., & Chen, L.-F. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2010.03.017 · Cited by 343
Genetic analysis of NF- B/Rel transcription factors defines functional specificities
Hoffmann, A. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg534 · Cited by 329
CK2 Is a C-Terminal IκB Kinase Responsible for NF-κB Activation during the UV Response
Kato, T., Delhase, M., Hoffmann, A., & Karin, M. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00358-7 · Cited by 314
p53 stabilization is decreased upon NFκB activation
Tergaonkar, V., Pando, M., Vafa, O., Wahl, G., & Verma, I. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00068-5 · Cited by 313
Signaling to NF- B: Regulation by Ubiquitination
Wertz, I. E., & Dixit, V. M. (2010) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a003350 · Cited by 300
Classical and/or alternative NF-κB pathway activation in multiple myeloma
Demchenko, Y. N., Glebov, O. K., Zingone, A., Keats, J. J., Bergsagel, P. L., & Kuehl, W. M. (2010) · Blood · doi:10.1182/blood-2009-09-243535 · Cited by 288
Deubiquitinases in the regulation of NF-κB signaling
Harhaj, E. W., & Dixit, V. M. (2011) · Cell Research · doi:10.1038/cr.2010.166 · Cited by 261
Bohuslav, J., Chen, L.-F., Kwon, H., Mu, Y., & Greene, W. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313509200 · Cited by 256
Phosphorylation of Serine 468 by GSK-3β Negatively Regulates Basal p65 NF-κB Activity
Buss, H., Dörrie, A., Schmitz, M. L., Frank, R., Livingstone, M., Resch, K., & Kracht, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.c400442200 · Cited by 252
Huang, W.-C., Ju, T.-K., Hung, M.-C., & Chen, C.-C. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.02.019 · Cited by 240
Rocha, S., Martin, A. M., Meek, D. W., & Perkins, N. D. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.13.4713-4727.2003 · Cited by 239
Self-citationA nuclear poly(ADP-Ribose)-dependent signalosome confers DNA damage-induced IκB kinase activation.
Stilmann, M., Hinz, M., Arslan, S. Ç., Zimmer, A., Schreiber, V., & Scheidereit, C. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.032 · Cited by 232
Grossmann, M. (2000) · The EMBO Journal · doi:10.1093/emboj/19.23.6351 · Cited by 227
Mechanism of Hypoxia-Induced NF-κB
Culver, C., Sundqvist, A., Mudie, S., Melvin, A., Xirodimas, D., & Rocha, S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00409-10 · Cited by 223
Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression
Teo, H., Ghosh, S., Luesch, H., Ghosh, A., Wong, E. T., Malik, N., Orth, A., de Jesus, P., Perry, A. S., Oliver, J. D., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2080 · Cited by 222
Essential Cytoplasmic Translocation of a Cytokine Receptor–Assembled Signaling Complex
Matsuzawa, A., Tseng, P.-H., Vallabhapurapu, S., Luo, J.-L., Zhang, W., Wang, H., Vignali, D. A. A., Gallagher, E., & Karin, M. (2008) · Science · doi:10.1126/science.1157340 · Cited by 217
TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
Bettermann, K., Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.021 · Cited by 217
Wu, Z.-H., Wong, E. T., Shi, Y., Niu, J., Chen, Z., Miyamoto, S., & Tergaonkar, V. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.09.010 · Cited by 207
Beinke, S., Robinson, M. J., Hugunin, M., & Ley, S. C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9658-9667.2004 · Cited by 204
Multiple mutations contribute to the oncogenicity of the retroviral oncoprotein v-Rel
Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203222 · Cited by 200
Mutant p53 Enhances Nuclear Factor κB Activation by Tumor Necrosis Factor α in Cancer Cells
Weisz, L., Damalas, A., Liontos, M., Karakaidos, P., Fontemaggi, G., Maor-Aloni, R., Kalis, M., Levrero, M., Strano, S., Gorgoulis, V. G., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2425 · Cited by 199
Activation of nuclear factor-kappa B signalling promotes cellular senescence
Rovillain, E., Mansfield, L., Caetano, C., Alvarez-Fernandez, M., Caballero, O. L., Medema, R. H., Hummerich, H., & Jat, P. S. (2011) · Oncogene · doi:10.1038/onc.2010.611 · Cited by 197
CREB-binding Protein Is a Nuclear Integrator of Nuclear Factor-κB and p53 Signaling
Wadgaonkar, R., Phelps, K. M., Haque, Z., Williams, A. J., Silverman, E. S., & Collins, T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1879 · Cited by 192
Requirement of the NF-κB Subunit p65/RelA for K-Ras–Induced Lung Tumorigenesis
Bassères, D. S., Ebbs, A., Levantini, E., & Baldwin, A. S. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4290 · Cited by 189
p53- and Mdm2-Independent Repression of NF-κB Transactivation by the ARF Tumor Suppressor
Rocha, S., Campbell, K. J., & Perkins, N. D. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00223-5 · Cited by 189
Self-citationThe nuclear signaling of NF-KB: current knowledge, new insights, and future perspectives
Fengyi, Wan, Michael, M., & Lenardo (2010) · Acta Scientiarum Naturalium Universitatis Sunyatseni · Cited by 188
IκBβ acts to inhibit and activate gene expression during the inflammatory response
Rao, P., Hayden, M. S., Long, M., Scott, M. L., West, A. P., Zhang, D., Oeckinghaus, A., Lynch, C., Hoffmann, A., Baltimore, D., et al. (2010) · Nature · doi:10.1038/nature09283 · Cited by 186
The Putative Oncoprotein Bcl-3 Induces Cyclin D1 To Stimulate G1 Transition
Westerheide, S. D., Mayo, M. W., Anest, V., Hanson, J. L., & Baldwin, A. S. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.24.8428-8436.2001 · Cited by 182
Takada, Y., Singh, S., & Aggarwal, B. B. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311192200 · Cited by 179
p53 and NF‐κB: different strategies for responding to stress lead to a functional antagonism
Ak, P., & Levine, A. J. (2010) · The FASEB Journal · doi:10.1096/fj.10-160549 · Cited by 178
The NF-κB-independent functions of IKK subunits in immunity and cancer
Chariot, A. (2009) · Trends in Cell Biology · doi:10.1016/j.tcb.2009.05.006 · Cited by 176
Population robustness arising from cellular heterogeneity
Paszek, P., Ryan, S., Ashall, L., Sillitoe, K., Harper, C. V., Spiller, D. G., Rand, D. A., & White, M. R. H. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0913798107 · Cited by 176
WIP1 phosphatase is a negative regulator of NF-κB signalling
Chew, J., Biswas, S., Shreeram, S., Humaidi, M., Wong, E. T., Dhillion, M. K., Teo, H., Hazra, A., Fang, C. C., López-Collazo, E., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1873 · Cited by 172
Double-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 169
NF-κB Activation Mediates Doxorubicin-induced Cell Death in N-type Neuroblastoma Cells
Bian, X., McAllister‐Lucas, L. M., Shao, F., Schumacher, K. R., Feng, Z., Porter, A. G., Castle, V. P., & Opipari, A. W. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108674200 · Cited by 166
Regulation of NF‐κB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor
Rocha, S., Garrett, M. D., Campbell, K. J., Schumm, K., & Perkins, N. D. (2005) · The EMBO Journal · doi:10.1038/sj.emboj.7600608 · Cited by 162
Self-citationGumá, M., Stepniak, D. T., Shaked, H., Spehlmann, M. E., Shenouda, S., Cheroutre, H., Vicente-Suarez, I., Eckmann, L., Kagnoff, M. F., & Karin, M. (2011) · The Journal of Experimental Medicine · doi:10.1084/jem.20110242 · Cited by 162
Regulation of Programmed Cell Death by NF-κB and its Role in Tumorigenesis and Therapy
Fan, Y., Dutta, J., Gupta, N., Fan, G., & Gélinas, C. (2007) · Advances in experimental medicine and biology · doi:10.1007/978-1-4020-6554-5_11 · Cited by 156
Geng, H. Z., Wittwer, T., Dittrich‐Breiholz, O., Kracht, M., & Schmitz, M. L. (2009) · EMBO Reports · doi:10.1038/embor.2009.10 · Cited by 155
Adli, M., & Baldwin, A. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603133200 · Cited by 155
p53-mediated repression of nuclear factor-kappaB RelA via the transcriptional integrator p300.
Ravi, R. K., Mookerjee, B., van Hensbergen, Y., Bedi, G. C., Giordano, A., El‐Deiry, W. S., Fuchs, E. J., & Bedi, A. (1998) · PubMed · Cited by 155
Regulation of p53 tumour suppressor target gene expression by the p52 NF‐κB subunit
Schumm, K., Rocha, S., Caamaño, J., & Perkins, N. D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601343 · Cited by 153
Self-citationCross talk between stimulated NF-κB and the tumor suppressor p53
Schneider, G., Henrich, A., Greiner, G., Wolf, V, Lovas, A., Wieczorek, M., Wagner, T., Reichardt, S., von Werder, A., Schmid, R. M., et al. (2010) · Oncogene · doi:10.1038/onc.2010.46 · Cited by 149
Many faces of NF-κB signaling induced by genotoxic stress
Wu, Z., & Miyamoto, S. (2007) · Journal of Molecular Medicine · doi:10.1007/s00109-007-0227-9 · Cited by 147
Moreno, R., Sobotzik, J.-M., Schultz, C., & Schmitz, M. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq439 · Cited by 140
Shetty, S., Graham, B. A., Brown, J. G., Hu, X., Vegh-Yarema, N., Harding, G. A., Paul, J. T., & Gibson, S. B. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.13.5404-5416.2005 · Cited by 139
Ubiquitination and Degradation of the Inhibitors of NF- BPreprint
Kanarek, N., London, N., Schueler‐Furman, O., & Ben‐Neriah, Y. (2009) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a000166 · Cited by 137
Repression of gene expression by unphosphorylated NF-κB p65 through epigenetic mechanismsPreprint
Dong, J., Jimi, E., Zhong, H., Hayden, M. S., & Ghosh, S. (2008) · Genes & Development · doi:10.1101/gad.1657408 · Cited by 137
Structural studies of NF-κB signaling
Zheng, C., Yin, Q., & Wu, H. (2011) · Cell Research · doi:10.1038/cr.2010.171 · Cited by 134
IκB Kinase Is an Essential Component of the Tpl2 Signaling Pathway
Waterfield, M. R., Jin, W., Reiley, W. W., Zhang, M., & Sun, S. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.13.6040-6048.2004 · Cited by 134
GCN5 is a required cofactor for a ubiquitin ligase that targets NF-κB/RelAPreprint
Mao, X., Gluck, N., Li, D., Maine, G. N., Li, H., Zaidi, I. W., Repaka, A., Mayo, M. W., & Burstein, E. (2009) · Genes & Development · doi:10.1101/gad.1748409 · Cited by 133
p53-Dependent Regulation of Mitochondrial Energy Production by the RelA Subunit of NF-κB
Johnson, R., Witzel, I., & Perkins, N. D. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4252 · Cited by 132
Self-citationOakley, F., Teoh, V. W. Y., Ching-A-Sue, G., Bataller, R. A., Colmenero, J., Jonsson, J. R., Eliopoulos, A. G., Watson, M. R., Manas, D., & Mann, D. A. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.02.081 · Cited by 130
Mayo, M. W., Madrid, L. V., Westerheide, S. D., Jones, D. R., Yuan, X., Baldwin, A. S., & Whang, Y. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108670200 · Cited by 123
Frank, A. K., Leu, J. I.-J., Zhou, Y., Devarajan, K., Nedelko, T., Klein–Szanto, A. J., Hollstein, M. C., & Murphy, M. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01136-10 · Cited by 117
Opposing roles of NF-κB in anti-cancer treatment outcome unveiled by cross-species investigations
Hua, J., Kase, J., Dörr, J. R., Milanovic, M., Lenze, D., Grau, M., Beuster, G., Ji, S., Reimann, M., Lenz, P., et al. (2011) · Genes & Development · doi:10.1101/gad.17620611 · Cited by 111
Inhibition of NF-κB Signaling as a Strategy in Disease Therapy
Gilmore, T. D., & Garbati, M. R. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_105 · Cited by 109
van Essen, D., Zhu, Y., & Saccani, S. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.08.010 · Cited by 107
LZAP, a Putative Tumor Suppressor, Selectively Inhibits NF-κB
Wang, J., An, H., Mayo, M. W., Baldwin, A. S., & Yarbrough, W. G. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.002 · Cited by 106
Renner, F., Moreno, R., & Schmitz, M. L. (2010) · Molecular Cell · doi:10.1016/j.molcel.2010.01.018 · Cited by 104
Anrather, J., Racchumi, G., & Iadecola, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409344200 · Cited by 102
Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice
Vlantis, K., Wullaert, A., Sasaki, Y., Schmidt‐Supprian, M., Rajewsky, K., Roskams, T., & Pasparakis, M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45349 · Cited by 101
Zotti, T., Uva, A., Ferravante, A., Vessichelli, M., Scudiero, I., Ceccarelli, M., Vito, P., & Stilo, R. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.215426 · Cited by 100
Ho, W. C., Dickson, K. M., & Barker, P. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3494 · Cited by 95
RelA/p65 functions to maintain cellular senescence by regulating genomic stability and DNA repair
Wang, J., Jacob, N. K., Ladner, K. J., Beg, A. A., Perko, J. D., Tanner, S. M., Liyanarachchi, S., Fishel, R. A., & Guttridge, D. C. (2009) · EMBO Reports · doi:10.1038/embor.2009.197 · Cited by 91
The Biphasic Role of NF-κB in Progression and Chemoresistance of Ovarian Cancer
Yang, G. S., Xiao, X., Rosen, D. G., Cheng, X., Wu, X., Chang, B., Liu, G., Xue, F., Mercado‐Uribe, I., Chiao, P. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-3265 · Cited by 88
NFκB/p53 crosstalk—a promising new therapeutic target
Schneider, G., & Krämer, O. H. (2011) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.10.003 · Cited by 87
INK4 cell cycle inhibitors direct transcriptional inactivation of NF-κB
Wolff, B., & Naumann, M. (1999) · Oncogene · doi:10.1038/sj.onc.1202617 · Cited by 85
Wu, Z., & Miyamoto, S. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.127 · Cited by 85
Lü, H., Yang, X., Duggal, P., Allen, C. T., Yan, B., Cohen, J., Nottingham, L. K., Romano, R.-A., Sinha, S., King, K. E., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-2460 · Cited by 81
Cisplatin Mimics ARF Tumor Suppressor Regulation of RelA (p65) Nuclear Factor-κB Transactivation
Campbell, K. J., Witty, J., Rocha, S., & Perkins, N. D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2234 · Cited by 79
Self-citationMultiple Myeloma: Lusting for NF-κB
Gilmore, T. D. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.010 · Cited by 77
Lee, T., Yang, X. P., Yan, B., Friedman, J., Duggal, P., Bagain, L., Dong, G., Yeh, N. T., Wang, J., Zhou, J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0670 · Cited by 76
Regulation of the RelA (p65) transactivation domain
O'shea, J. M., & Perkins, N. D. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360603 · Cited by 75
Self-citationRegulation of NF-κB activity by competition between RelA acetylation and ubiquitination
Li, H., Wittwer, T., Weber, A., Schneider, H., Moreno, R., Maine, G. N., Kracht, M., Schmitz, M. L., & Burstein, E. (2011) · Oncogene · doi:10.1038/onc.2011.253 · Cited by 74
Nutlin-3 inhibits the NFκB Pathway in a p53 Dependent Manner: Implications in Lung Cancer Therapy
Dey, A., Wong, E. T., Bist, P., Tergaonkar, V., & Lane, D. (2007) · Cell Cycle · doi:10.4161/cc.6.17.4643 · Cited by 70
Identification of a novel pro‐apopotic function of NF‐κB in the DNA damage response
Karl, S., Pritschow, Y., Volčič, M., Häcker, S., Baumann, B., Wiesmüller, L., Debatin, K., & Fulda, S. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00888.x · Cited by 63
Mbalaviele, G., Sommers, C. D., Bonar, S. L., Mathialagan, S., Schindler, J. F., Guzova, J. A., Shaffer, A. F., Melton, M. A., Christine, L. J., Tripp, C. S., et al. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143800 · Cited by 63
Identification of possible genetic polymorphisms involved in cancer cachexia: a systematic review
Tan, B. H. L., Ross, J. A., Kaasa, S., Skorpen, F., & Fearon, K. C. H. (2011) · Journal of Genetics · doi:10.1007/s12041-011-0027-4 · Cited by 58
Strozyk, E. A., Pöppelmann, B., Schwarz, T., & Kulms, D. (2006) · Oncogene · doi:10.1038/sj.onc.1209655 · Cited by 58
Variants of the RELA Gene are Associated with Schizophrenia and their Startle Responses
Hashimoto, R., Ohi, K., Yasuda, Y., Fukumoto, M., Yamamori, H., Takahashi, H., Iwase, M., Okochi, T., Kazui, H., Saitoh, O., et al. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2011.78 · Cited by 53
Ostrander, J. H., Hawke, N. A., Kashatus, D. F., & Baldwin, A. S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3898 · Cited by 52
The clinical development of inhibitors of poly(ADP-ribose) polymerase
Calvert, H., & Azzariti, A. (2011) · Annals of Oncology · doi:10.1093/annonc/mdq667 · Cited by 52
Nuclear factor-kappa B inhibitors; a patent review (2006 – 2010)
Kwak, J., Jung, J., & Lee, H. (2011) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2011.638285 · Cited by 48
Msaki, A., Sanchez, A. M., Koh, L. F., Barré, B., Rocha, S., Perkins, N. D., & Johnson, R. (2011) · Molecular Biology of the Cell · doi:10.1091/mbc.e11-04-0280 · Cited by 45
Self-citationChIP-on-Chip Analysis of In Vivo Mutant p53 Binding To Selected Gene Promoters
Dell’Orso, S., Fontemaggi, G., Stambolsky, P., Goeman, F., Voellenkle, C., Levrero, M., Strano, S., Rotter, V., Oren, M., & Blandino, G. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0084 · Cited by 44
NF-κB mediates radio-sensitization by the PARP-1 inhibitor, AG-014699
Hunter, J. E., Willmore, E., Irving, J. A. E., Hostomský, Z., Veuger, S. J., & Durkacz, B. W. (2011) · Oncogene · doi:10.1038/onc.2011.229 · Cited by 40
Activation of p73 and induction of Noxa by DNA damage requires NF-kappa B
Martín, Á. G., Trama, J. P., Crighton, D., Ryan, K. M., & Fearnhead, H. O. (2009) · Aging · doi:10.18632/aging.100026 · Cited by 40
IKK and NF‐κB‐mediated regulation of Claspin impacts on ATR checkpoint function
Kenneth, N. S., Mudie, S., & Rocha, S. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.171 · Cited by 38
p53-mediated induction of Noxa and p53AIP1 requires NFκB
O’Prey, J., Crighton, D., Martín, Á. G., Vousden, K. H., Fearnhead, H. O., & Ryan, K. M. (2010) · Cell Cycle · doi:10.4161/cc.9.5.10872 · Cited by 37
Choy, M., Movassagh, M., Siggens, L., Vujić, A., Goddard, M. J., Sanchez, A. M., Perkins, N. D., Figg, N. L., Bennett, M. R., Carroll, J. S., et al. (2010) · Genome Medicine · doi:10.1186/gm158 · Cited by 36
Self-citationStarczynowski, D. T., Trautmann, H., Pott, C., Harder, L., Arnold, N., Africa, J. A., Leeman, J. R., Siebert, R., & Gilmore, T. D. (2006) · Oncogene · doi:10.1038/sj.onc.1210089 · Cited by 33
CHFR, a potential tumor suppressor, downregulates interleukin-8 through the inhibition of NF-κB
Kashima, L., Toyota, M., Mita, H., Suzuki, H., Idogawa, M., Ogi, K., Sasaki, Y., & Tokino, T. (2009) · Oncogene · doi:10.1038/onc.2009.123 · Cited by 31
Association Between NFKB1 -94ins/delATTG Promoter Polymorphism and Cancer Risk: A Meta-Analysis
Zou, Y., Yuan, F., Feng, X.-L., Tao, J., Ding, N., Pan, F., & Wang, F. (2010) · Cancer Investigation · doi:10.3109/07357907.2010.535054 · Cited by 27
NF-κB Potentiates Caspase Independent Hydrogen Peroxide Induced Cell Death
Ho, J. Q., Asagiri, M., Hoffmann, A., & Ghosh, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016815 · Cited by 24
Thr435 phosphorylation regulates RelA (p65) NF-κB subunit transactivation
O'Shea, J. M., & Perkins, N. D. (2009) · Biochemical Journal · doi:10.1042/bj20091630 · Cited by 24
Self-citationAvila, C. M., Lopes, A. B., Gonçalves, A. D. S., da Silva, L. L., Romeiro, N. C., Miranda, A. L. P., Sant’Anna, C. M. R., Barreiro, E. J., & Fraga, C. A. M. (2011) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2011.01.045 · Cited by 23
Oh, U., McCormick, M. J., Datta, D., Turner, R. V., Bobb, K., Monie, D. D., Sliskovic, D. R., Tanaka, Y., Zhang, J., Meshulam, J., et al. (2011) · Blood · doi:10.1182/blood-2010-10-306571 · Cited by 17
Inverse correlation between p16INK4A expression and NF-κB activation in melanoma progression
Ghiorzo, P., Mantelli, M., Gargiulo, S., Gramigni, C., Pastorino, L., Banelli, B., Villaggio, B., Coccia, M. C., Sementa, A. R., Garrè, C., et al. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.02.017 · Cited by 15
Discovery of piperidinyl aminopyrimidine derivatives as IKK-2 inhibitors
Kim, S., Jung, J. K., Lee, H. S., Kim, Y.-J., Kim, J., Choi, K., Baek, D.-J., Moon, B., Oh, K., Lee, B. H., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.03.044 · Cited by 14
Gapuzan, M.-E. R., Pitoc, G. A., & Gilmore, T. D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01123-9 · Cited by 8
Chiang, P., Kishore, N. N., & Thompson, D. C. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21909 · Cited by 6
Research works printed but not linked: 7
- Barre, B. & Perkins, N. D. Phosphorylation of the p52 NF-κB subunit. Cell cycle 9, 4774–4775 (2010). · doi:10.4161/cc.9.24.14246
- Rattan, R. et al. TCEAL7, a putative tumor suppressor gene, negatively regulates NF-κB pathway. Oncogene 29, 1362–1373 (2010). · doi:10.1038/onc.2009.431
- Bednarski, B. K., Baldwin, A. S. Jr & Kim, H. J. Addressing reported pro-apoptotic functions of NF-κB: targeted inhibition of canonical NF-κB enhances the apoptotic effects of doxorubicin. PLoS ONE 4, e6992 (2009). · doi:10.1371/journal.pone.0006992
- Campbell, K. J., O'Shea, J. M. & Perkins, N. D. Differential regulation of NF-κB activation and function by topoisomerase II inhibitors. BMC Cancer 6, 101 (2006). · doi:10.1186/1471-2407-6-101
- Manna, S. K., Manna, P. & Sarkar, A. Inhibition of RelA phosphorylation sensitizes apoptosis in constitutive NF-κB-expressing and chemoresistant cells. Cell Death Differ. 14, 158–170 (2007). · doi:10.1038/sj.cdd.4401929
- Roccaro, A. M., Vacca, A. & Ribatti, D. Bortezomib in the treatment of cancer. Recent Pat. Anticancer Drug Discov. 1, 397–403 (2006). · doi:10.2174/157489206778776925
- Trecca, D. et al. Identification of a tumor-associated mutant form of the NF- κB RelA gene with reduced DNA-binding and transactivating activities. Oncogene 14, 791–799 (1997). · doi:10.1038/sj.onc.1200895
Cited by
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
NF-κB, inflammation, immunity and cancer: coming of age
Taniguchi, K., & Karin, M. (2018) · Nature Reviews Immunology · doi:10.1038/nri.2017.142 · Cited by 2,679
Hayes, J. D., Dinkova-Kostova, A. T., & Tew, K. D. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.001 · Cited by 2,654
NF-κB in biology and targeted therapy: new insights and translational implications
Guo, Q., Jin, Y., Chen, X., Ye, X., Shen, X., Lin, M., Zeng, C., Zhou, T., & Zhang, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01757-9 · Cited by 2,047
30 Years of NF-κB: A Blossoming of Relevance to Human Pathobiology
Zhang, Q., Lenardo, M. J., & Baltimore, D. (2017) · Cell · doi:10.1016/j.cell.2016.12.012 · Cited by 1,982
Metadata
- Authors
- Perkins, N. D.
- Venue
- Nature Reviews Cancer
- Published
- 2012-01-19
- Volume
- 12
- Issue
- 2
- Pages
- 121-132
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2042073539
- Cited by
- 852
- References
- 159
- FWCI
- 4.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.